AAAAAA
Results:
1-17
|
Results: 17
Authors:
Bechler, M
Ritter, H
Schiller, JH
Citation: M. Bechler et al., Quality of service in mobile and wireless networks: The need for proactiveand adaptive applications, TELECOM SYS, 18(1-3), 2001, pp. 227-242
Authors:
Schiller, JH
Adak, S
Cella, D
DeVore, RF
Johnson, DH
Citation: Jh. Schiller et al., Topotecan versus observation after cisplatin plus etoposide in extensive-stage small-cell lung cancer: E7593 - A phase III trial of the Eastern Cooperative Oncology Group, J CL ONCOL, 19(8), 2001, pp. 2114-2122
Authors:
Schiller, JH
Adak, S
Feins, RH
Keller, SM
Fry, WA
Livingston, RB
Hammond, MEM
Wolf, B
Sabatini, L
Jett, J
Kohman, L
Johnson, DH
Citation: Jh. Schiller et al., Lack of prognostic significance of p53 and K-ras mutations in primary resected non-small-cell lung cancer on E4592: A laboratory ancillary study on an Eastern Cooperative Oncology Group prospective randomized trial of postoperative adjuvant therapy, J CL ONCOL, 19(2), 2001, pp. 448-457
Authors:
Leu, KM
Kim, KM
Larson, M
Larson, M
Schiller, JH
Citation: Km. Leu et al., Phase I/II trial of docetaxel and vinorelbine in patients with non-small cell lung cancer previously treated with platinum-based chemotherapy, LUNG CANC, 34(1), 2001, pp. 105-113
Authors:
Schiller, JH
Citation: Jh. Schiller, Novel therapies in lung cancer management - An update on the role of topotecan, ONCOL-BASEL, 61, 2001, pp. 1-2
Authors:
Schiller, JH
Citation: Jh. Schiller, Current standards of care in small-cell and non-small-cell lung cancer, ONCOL-BASEL, 61, 2001, pp. 3-13
Authors:
Schiller, JH
Citation: Jh. Schiller, Future role of topotecan in the treatment of lung cancer, ONCOL-BASEL, 61, 2001, pp. 55-59
Authors:
Eastman, ME
Khorsand, M
Maki, DG
Williams, EC
Kim, K
Sondel, PM
Schiller, JH
Albertini, MR
Citation: Me. Eastman et al., Central venous device-related infection and thrombosis in patients treatedwith moderate dose continuous-infusion interleukin-2, CANCER, 91(4), 2001, pp. 806-814
Authors:
Cunningham, CC
Holmlund, JT
Schiller, JH
Geary, RS
Kwoh, TJ
Dorr, A
Nemunaitis, J
Citation: Cc. Cunningham et al., A phase I trial of c-raf kinase antisense oligonucleotide ISIS 5132 administered as a continuous intravenous infusion in patients with advanced cancer, CLIN CANC R, 6(5), 2000, pp. 1626-1631
Authors:
Vandenbergh, DJ
Rodriguez, LA
Hivert, E
Schiller, JH
Villareal, G
Pugh, EW
Lachman, H
Uhl, GR
Citation: Dj. Vandenbergh et al., Long forms of the dopamine receptor (DRD4) gene VNTR are more prevalent insubstance abusers: No interaction with functional alleles of the catechol-o-methyltransferase (COMT) gene, AM J MED G, 96(5), 2000, pp. 678-683
Authors:
Hotton, KM
Khorsand, M
Hank, JA
Albertini, M
Kim, KM
Wilding, G
Salamat, MS
Larson, M
Sondel, P
Schiller, JH
Citation: Km. Hotton et al., A phase Ib/II trial of granulocyte-macrophage-colony stimulating factor and interleukin-2 for renal cell carcinoma patients with pulmonary metastases- A case of fatal central nervous system thrombosis, CANCER, 88(8), 2000, pp. 1892-1901
Authors:
Hank, JA
Surfus, J
Gan, J
Albertini, M
Lindstrom, M
Schiller, JH
Hotton, KM
Khorsand, M
Sondel, PM
Citation: Ja. Hank et al., Distinct clinical and laboratory activity of two recombinant interleukin-2preparations, CLIN CANC R, 5(2), 1999, pp. 281-289
Authors:
Schiller, JH
Bittner, G
Citation: Jh. Schiller et G. Bittner, Potentiation of platinum antitumor effects in human lung tumor xenografts by the angiogenesis inhibitor squalamine: Effects on tumor neovascularization, CLIN CANC R, 5(12), 1999, pp. 4287-4294
Authors:
von Pawel, J
Schiller, JH
Shepherd, FA
Fields, SZ
Kleisbauer, JP
Chrysson, NG
Stewart, DJ
Clark, PI
Palmer, MC
Depierre, A
Carmichael, J
Krebs, JB
Ross, G
Lane, SR
Gralla, R
Citation: J. Von Pawel et al., Topotecan versus cyclophosphamide, doxorubicin, and vincristine for the treatment of recurrent small-cell lung cancer, J CL ONCOL, 17(2), 1999, pp. 658-667
Authors:
Kolesar, JM
Johnson, CL
Freeberg, BL
Berlin, JD
Schiller, JH
Citation: Jm. Kolesar et al., Warfarin-5-FU interaction - A consecutive case series, PHARMACOTHE, 19(12), 1999, pp. 1445-1449
Authors:
Tester, WJ
Kim, KM
Krigel, RL
Bonomi, PD
Glick, JH
Asbury, RF
Kirkwood, JM
Blum, RH
Schiller, JH
Citation: Wj. Tester et al., A randomized Phase II study of interleukin-2 with and without beta-interferon for patients with advanced non-small cell lung cancer - An Eastern Cooperative Oncology Group study (PZ586), LUNG CANC, 25(3), 1999, pp. 199-206
Authors:
Schiller, JH
Citation: Jh. Schiller, Future directions in non-small cell lung cancer, SEMIN ONCOL, 26(2), 1999, pp. 120-124
Risultati:
1-17
|